Susan Denman

Susan Denman is a seasoned executive with extensive experience in digital transformation and advisory services, currently serving as a Digital Transformation Advisor at Jazz Pharmaceuticals since September 2025. Additionally, Denman is a Bain External Advisor and a member of Extraordinary Women on Boards, contributing insights to drive strategic impact across various industries. As CEO and Managing Partner of Susan Denman Group LLC, advisory services focus on growth strategies, patient-centric marketing, and digital transformation. Denman's board involvement includes positions on the boards of Spinal Elements, as a Senior Advisor at Kohlberg & Company, and as an Advisory Board Member at Trinity Life Sciences. Denman has a distinguished educational background with an MBA in Marketing and Finance from The Wharton School, a BA in Economics and German from Duke University, and ongoing executive education at the Massachusetts Institute of Technology.